Immunic receives European patent protecting relevant dosing regimens for vidofludimus calcium: New York Thursday, March 12, 2026, 12:00 Hrs [IST] Immunic, Inc., a late-stage biote ...

In ‘Evaluating Transthyretin Stabilizers and Silencers in ATTR-CM,’ our panel delves into the segment by asking Dr. Alexander to explain the differences between transthyretin ...